Jules Cohen

2.7k total citations
91 papers, 1.8k citations indexed

About

Jules Cohen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Jules Cohen has authored 91 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 14 papers in Oncology. Recurrent topics in Jules Cohen's work include Computational Drug Discovery Methods (8 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Jules Cohen is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Jules Cohen collaborates with scholars based in United States, Netherlands and Canada. Jules Cohen's co-authors include M.G.P.J. Warringa, C. H. W. Leeksma, R.A. Oosterbaan, H.S. Jansz, David Scherf, C M Oakley, R. E. Steiner, J. F. Goodwin, Julian M. Aroesty and Marshall A. Lichtman and has published in prestigious journals such as Nature, Circulation and Journal of Clinical Investigation.

In The Last Decade

Jules Cohen

86 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jules Cohen United States 27 522 441 217 193 167 91 1.8k
M Hichens United States 27 631 1.2× 368 0.8× 184 0.8× 80 0.4× 92 0.6× 52 1.9k
Rita Müller Switzerland 19 625 1.2× 759 1.7× 144 0.7× 50 0.3× 152 0.9× 49 1.8k
Henry Fliss Canada 23 1.1k 2.0× 439 1.0× 60 0.3× 125 0.6× 258 1.5× 36 2.1k
Teresa Gessner United States 18 508 1.0× 193 0.4× 73 0.3× 166 0.9× 38 0.2× 57 1.6k
Erwin Bischoff Germany 24 826 1.6× 159 0.4× 157 0.7× 91 0.5× 150 0.9× 49 2.0k
C.N. Hensby United Kingdom 24 313 0.6× 135 0.3× 618 2.8× 106 0.5× 172 1.0× 73 1.6k
E. Arrigoni‐Martelli Denmark 24 586 1.1× 189 0.4× 240 1.1× 56 0.3× 114 0.7× 90 1.6k
M. Rosseneu Belgium 37 1.1k 2.1× 559 1.3× 177 0.8× 148 0.8× 169 1.0× 112 3.6k
Nobuyuki Marui Japan 21 1.0k 2.0× 618 1.4× 190 0.9× 169 0.9× 449 2.7× 39 2.7k
Yoshiaki Watanabe Japan 24 664 1.3× 367 0.8× 110 0.5× 72 0.4× 55 0.3× 150 2.2k

Countries citing papers authored by Jules Cohen

Since Specialization
Citations

This map shows the geographic impact of Jules Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jules Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jules Cohen more than expected).

Fields of papers citing papers by Jules Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jules Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jules Cohen. The network helps show where Jules Cohen may publish in the future.

Co-authorship network of co-authors of Jules Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Jules Cohen. A scholar is included among the top collaborators of Jules Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jules Cohen. Jules Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Karan, et al.. (2023). Association of patient age and insurance status with in-hospital mortality for patients with lung cancer.. Journal of Clinical Oncology. 41(16_suppl). e13669–e13669.
2.
Cohen, Jules, et al.. (2023). Utility of Stereotactic Body Radiation Therapy in Establishing Local Control for Patients With Invasive Breast Cancer Not Undergoing Definitive Surgery. International Journal of Radiation Oncology*Biology*Physics. 118(2). 436–442. 4 indexed citations
3.
Li, Kaixuan, Mingqian Wang, Patricia Alfonso, et al.. (2023). Synthesis and Preclinical Evaluation of a Novel Fluorine-18-Labeled Tracer for Positron Emission Tomography Imaging of Bruton’s Tyrosine Kinase. ACS Pharmacology & Translational Science. 6(3). 410–421. 2 indexed citations
4.
Martinez, Jessica A., Betsy C. Wertheim, Denise J. Roe, et al.. (2022). Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer. Breast Cancer Research and Treatment. 192(1). 113–122. 6 indexed citations
5.
Liu, Daxing, et al.. (2022). PEG2000-DBCO surface coating increases intracellular uptake of liposomes by breast cancer xenografts. Scientific Reports. 12(1). 10564–10564. 6 indexed citations
6.
7.
Biegon, Anat, et al.. (2019). Initial Studies with 11C-Vorozole PET Detect Overexpression of Intratumoral Aromatase in Breast Cancer. Journal of Nuclear Medicine. 61(6). 807–813. 4 indexed citations
8.
Cattell, Renee, Haifang Li, R. Vanguri, et al.. (2019). Convolutional Neural Network Detection of Axillary Lymph Node Metastasis Using Standard Clinical Breast MRI. Clinical Breast Cancer. 20(3). e301–e308. 46 indexed citations
9.
Cattell, Renee, James Kang, Haifang Li, et al.. (2019). MRI Volume Changes of Axillary Lymph Nodes as Predictor of Pathologic Complete Responses to Neoadjuvant Chemotherapy in Breast Cancer. Clinical Breast Cancer. 20(1). 68–79.e1. 12 indexed citations
10.
Cohen, Jules, et al.. (2019). Efficacy and toxicity of CDK 4/6 inhibitors in breast cancer: Systematic review and meta-analysis of the phase III clinical trials.. Journal of Clinical Oncology. 37(15_suppl). e14591–e14591. 3 indexed citations
11.
Junghaenel, Doerte U., et al.. (2015). Identification of distinct fatigue trajectories in patients with breast cancer undergoing adjuvant chemotherapy. Supportive Care in Cancer. 23(9). 2579–2587. 25 indexed citations
12.
Jhaveri, Kenar D., et al.. (2009). Treatment of refractory thrombotic thrombocytopenic purpura using multimodality therapy including splenectomy and cyclosporine. Transfusion and Apheresis Science. 41(1). 19–22. 10 indexed citations
13.
Haider, Asifa, Jules Cohen, Fei Ji, et al.. (2007). Insights into Gene Modulation by Therapeutic TNF and IFNγ Antibodies: TNF Regulates IFNγ Production by T Cells and TNF-Regulated Genes Linked to Psoriasis Transcriptome. Journal of Investigative Dermatology. 128(3). 655–666. 31 indexed citations
14.
Daniel, A, et al.. (1978). The relationships among arterial oxygen flow rate, oxygen binding by hemoglobin, and oxygen utilization in chronic cardiac decompensation.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 91(4). 635–49. 11 indexed citations
15.
Karch, Fred E., et al.. (1977). Evidence for a histamine-component of the heart rate response to stellate ganglion stimulation. Pharmacological Research Communications. 9(6). 553–562. 3 indexed citations
16.
Benfey, B. G., et al.. (1974). DISSOCIATION OF 5‐HYDROXYTRYPTAMINE EFFECTS ON MYOCARDIAL CONTRACTILITY AND CYCLIC AMP ACCUMULATION. British Journal of Pharmacology. 50(4). 581–585. 14 indexed citations
17.
Jansz, H.S., et al.. (1959). On the active site of horse-liver ali esterase I. Reaction of the enzyme with diisopropylphosphorofluoridate. Biochimica et Biophysica Acta. 33(2). 387–395. 29 indexed citations
18.
Oosterbaan, R.A., et al.. (1958). The reaction of chymotrypsin and diisopropylphosphofluoridate I. Isolation and analysis of Diisopropylphosphoryl-peptides. Biochimica et Biophysica Acta. 27(3). 549–555. 39 indexed citations
19.
Cohen, Jules & M.G.P.J. Warringa. (1954). The Fate of P32 Labelled Diisopropylfluorophosphonate in the Human Body and Its Use as a Labelling Agent in the Study Of The Turnover of Blood Plasma and Red Cells. Journal of Clinical Investigation. 33(3). 459–467. 79 indexed citations
20.
Cohen, Jules & M.G.P.J. Warringa. (1953). Purification of cholinesterase from ox red cells. Biochimica et Biophysica Acta. 10(2). 195–196. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Hichens Breakdown of academic impact, for papers by Rita Müller Breakdown of academic impact, for papers by Henry Fliss Breakdown of academic impact, for papers by Teresa Gessner Breakdown of academic impact, for papers by Erwin Bischoff Breakdown of academic impact, for papers by C.N. Hensby Breakdown of academic impact, for papers by E. Arrigoni‐Martelli Breakdown of academic impact, for papers by M. Rosseneu Breakdown of academic impact, for papers by Nobuyuki Marui Breakdown of academic impact, for papers by Yoshiaki Watanabe
Rankless by CCL
2026